Casdin Capital, LLC's Net Worth

$93.6 Million

Estimate Recalculated Oct 6, 2025 08:24PM EST

Who is Casdin Capital, LLC

Casdin Capital, LLC has an estimated net worth of $93.6 Million. This is based on reported shares across multiple companies, which include STANDARD BIOTOOLS INC., CONSTELLATION PHARMACEUTICALS INC, Fulcrum Therapeutics, Inc., Absci Corp, BIOLIFE SOLUTIONS INC, MAXCYTE, INC., GeneDx Holdings Corp., 2seventy bio, Inc., Generation Bio Co., and Tenaya Therapeutics, Inc..

SEC CIK

Casdin Capital, LLC's CIK is 0001534261

Past Insider Trading and Trends

2024 was Casdin Capital, LLC's most active year for acquiring shares with 11 total transactions. Casdin Capital, LLC's most active month to acquire stocks was the month of April. 2024 saw Casdin Capital, LLC paying a total of $8,595,013.82 for 448,975 shares, this is the most they've acquired in one year.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

STANDARD BIOTOOLS INC.

Investor
Updated Aug 29, 2024
Form 4
0.46%
250.00K
$2.19
$546.75K
Aug 29, 2024
74.04M
Purchase
Aug 27
Form 4
0.70%
750.00K
$2.09
$1.55M
Aug 26, 2024
127.41M
Purchase
Aug 22 - Aug 26
Form 4
2.37%
1.20M
$1.59
$1.91M
Aug 16, 2024
71.79M
Purchase
Aug 14
Form 4
3.22%
1.58M
$1.62
$2.56M
Aug 13, 2024
70.59M
Purchase
Aug 09 - Aug 13
Form 4
1.11%
1.07M
$1.61
$1.72M
Aug 09, 2024
117.44M
Purchase
Aug 07 - Aug 08
Form 4
$2.05
Jun 21, 2024
67.84M
Acq/Dis
Jun 18
Form 4
0.22%
100.00K
$2.60
$260.00K
May 28, 2024
71.61M
Purchase
May 23
Form 4
1.32%
600.00K
$2.57
$1.54M
May 22, 2024
71.51M
Purchase
May 20 - May 22
Form 4
3.07%
1.35M
$2.56
$3.46M
May 17, 2024
70.91M
Purchase
May 15 - May 17
Form 4
398.58%
46.34M
$2.75
$127.43M
Mar 20, 2024
69.56M
Acquisition
Mar 18
Form 4
2.24%
251.40K
$2.57
$646.17K
Mar 06, 2024
23.09M
Purchase
Mar 04 - Mar 05
Form 4
13.99M
Jan 09, 2024
15.19M
Grant
Jan 05
Form 4
1.20M
$2.19
$2.63M
May 19, 2023
1.20M
Purchase
May 17 - May 19
Form 4
127.78K
Apr 06, 2022
127.78K
Grant
Apr 04
Form 3
Apr 06, 2022
Showing 15 results

CONSTELLATION PHARMACEUTICALS INC

Investor
Updated Jul 23, 2018
Form 4
-85.10%
-4.40M
$15.00
Jul 23, 2018
771.41K
Buy-Options
Jul 23
Form 3
Jul 18, 2018
Showing 2 results

Fulcrum Therapeutics, Inc.

Investor
Updated Jul 22, 2019
Form 4
-81.41%
-2.65M
$15.84
Jul 22, 2019
604.29K
Buy-Options
Jul 22
Form 3
Jul 17, 2019
Showing 2 results

Absci Corp

Investor
Updated Jul 28, 2021
Form 4
139.64%
4.50M
$16.00
$25.00M
Jul 28, 2021
7.72M
Purchase
Jul 26
Form 3
Jul 21, 2021
Showing 2 results

BIOLIFE SOLUTIONS INC

Investor
Updated May 02, 2024
Form 4
$17.54
May 02, 2024
8.71M
Acq/Dis
Apr 30
Form 4
12.15%
927.16K
$11.19
$10.37M
Oct 23, 2023
8.71M
Purchase
Oct 19
Form 4
0.77%
58.47K
$13.20
$771.74K
Aug 11, 2023
7.78M
Purchase
Aug 09
Form 4
99.93%
74.97K
$22.32
$1.67M
May 23, 2023
7.72M
Purchase
May 19 - May 22
Form 4/A
1.77%
131.43K
May 19, 2023
7.57M
Acquisition
Sep 01
Form 4
75.03K
$21.26
$1.59M
May 18, 2023
7.65M
Purchase
May 16 - May 18
Form 4
1.70%
126.19K
Nov 03, 2021
7.57M
Acquisition
Sep 01
Form 4
27.40%
1.60M
$22.50
$36.00M
Nov 27, 2020
7.44M
Purchase
Nov 24
Form 4
20.43%
990.58K
$14.50
$14.36M
Jul 02, 2020
5.84M
Purchase
Jul 01 - Jul 02
Form 4
10.89%
476.19K
$10.50
$5.00M
May 26, 2020
4.85M
Purchase
May 22
Form 4
77.16%
1.90M
$10.50
$20.00M
May 18, 2020
4.37M
Purchase
May 14
Form 4
1.65%
40.00K
$15.41
$616.54K
Nov 21, 2019
2.47M
Purchase
Nov 19 - Nov 20
Form 3
Aug 15, 2018
2.43M
Showing 13 results

MAXCYTE, INC.

Investor
Updated Oct 05, 2022
Form 4
-6.85%
-735.79K
$6.15
-$4.53M
Oct 05, 2022
10.00M
Sale
Oct 03
Form 4
-23.16%
-3.24M
$4.30
-$13.91M
Jul 06, 2022
10.74M
Sale
Jul 01
Form 4
14.79%
1.80M
$13.00
$23.40M
Aug 03, 2021
13.97M
Purchase
Jul 30
Form 3
Jul 30, 2021
12.17M
Showing 4 results

GeneDx Holdings Corp.

Investor
Updated Jun 05, 2024
Form 4
4.39%
130.00K
$21.21
$2.76M
Jun 05, 2024
3.86M
Purchase
Jun 03 - Jun 04
Form 4
1.37%
40.00K
$21.07
$842.60K
May 31, 2024
3.73M
Purchase
May 29
Form 4
6.17%
170.00K
$20.15
$3.42M
May 28, 2024
3.69M
Purchase
May 23 - May 28
Form 4
1.85%
50.00K
$23.31
$1.17M
May 15, 2024
3.52M
Purchase
May 13
Form 4
1.54%
40.90K
$8.74
$357.65K
Mar 06, 2024
3.47M
Purchase
Mar 04 - Mar 05
Form 3
Feb 10, 2023
102.15M
Showing 6 results

2seventy bio, Inc.

Investor
Updated Jun 12, 2024
Form 4
108.89%
18.07K
$3.93
$47.36K
Jun 12, 2024
2.60M
Grant
Jun 10
Form 4
2.04%
40.00K
$5.10
$203.99K
Mar 28, 2024
2.02M
Purchase
Mar 26
Form 4
40.07%
714.23K
$4.87
$3.60M
Mar 25, 2024
2.51M
Purchase
Mar 21 - Mar 25
Form 3
Mar 25, 2024
1.20M
Showing 4 results

Generation Bio Co.

Investor
Updated Jun 18, 2020
Form 4
4.02%
62.30K
$19.00
Jun 18, 2020
1.61M
Purchase
Jun 16
Form 3
Jun 11, 2020
Showing 2 results

Tenaya Therapeutics, Inc.

Investor
Updated Nov 25, 2022
Form 4
107.23%
3.85M
$2.60
$10.00M
Nov 25, 2022
7.43M
Purchase
Nov 17
Form 4
31.06%
850.00K
$15.00
$12.75M
Aug 04, 2021
3.59M
Purchase
Aug 03
Form 3
Jul 29, 2021
Showing 3 results